With about 10 years of data now available, it’s becoming more and more clear that an aromatase inhibitor (AI) may be the hormone-therapy drug of choice for preventing breast cancer recurrence. Arimidex, Femara, and Aromasin—the drugs so many of us take on a daily basis—are proving more and more powerful as a cancer deterrent, for postmenopausal women with estrogen/progesterone-receptive cancer—which is a HUGE number of us.
Consider this: 95% of all new breast cancer cases are diagnosed...
